期刊文献+

慢病毒介导β-珠蛋白基因添加在β-地中海贫血基因治疗中的应用

Application of lentivirus- mediated β-globin gene addition in gene therapy of β-thalassemia
原文传递
导出
摘要 目的:构建全长人β-珠蛋白基因慢病毒载体,稳定转染K562细胞使得β-珠蛋白高效表达,为β-珠蛋白基因添加治疗奠定基础。方法:采用PCR扩增人正常β-珠蛋白基因,加上Sph I和Not I两个酶切位点进行T载体克隆,获得重组质粒p UC57-β-globin。用限制性内切酶连接目的基因片段和慢病毒载体,筛选获得慢病毒表达载体LV-β-globin,测序。将慢病毒载体转染293T细胞,包装病毒。用LV-β-globin感染K562细胞。采用流式细胞仪检测荧光效率,运用实时PCR及Western Blotting检测K562细胞中β-珠蛋白mRNA及蛋白表达情况。结果:通过PCR获得长度为2 128 bp的目的基因。连接p UC57载体和慢病毒表达载体,慢病毒表达载体LV-β-globin构建成功,序列正确。LV-β-globin转染K562细胞72 h后,显示大量绿色荧光表达,荧光效率为94.8%。β-珠蛋白mRNA 2-ΔΔCt值为4.080±0.078,高于对照组;β-珠蛋白灰度值为1.063±0.082,高于对照组,差异均有统计学意义(P<0.05)。结论:成功构建并包装含人β-珠蛋白基因的慢病毒载体并高效稳定表达。 Objective: To construct human β- globin gene lentiviral vector,transfect it into K562 cells to ensure high- efficiency expression of β- globin,lay the foundation for β- globin gene addition therapy. Methods: PCR was used to amplify human normal β- globin gene,T vector cloning was performed in Sph I and Not I restriction enzyme cutting sites to obtain recombinant plasmid p UC57- β- globin. Target gene segments and lentivirus vector were joined by restriction endonuclease,LV- β- globin was obtained after screening,then gene sequencing was conducted. Lentiviral vector was transfected into 293 T cells,then lentivirus was packaged. LV- β- globin was used to infect K562 cells. Flow cytometry was used to detect fluorescence efficiency,real- time PCR and Western Blotting were used to detect the expressions of β- globin mRNA and protein in K562 cells. Results: A length of 2 128 bp target gene sequence was obtained by PCR.p UC57 vector was connected to lentiviral expression vector. LV- β- globin was constructed successfully,the gene sequence was correct.LV- β- globin was transfected into K562 cells,after 72 hours,large green fluorescence was observed,fluorescence efficiency was 94. 8%.β- globin mRNA 2^-ΔΔCt value was 4. 080 ± 0. 078,which was higher than that in control group; grey value of β- globin was 1. 063 ± 0. 082,which was higher than that in control group,there were statistically significant differences( P〈0. 05). Conclusion: Lentiviral vector containing human β- globin gene is constructed and packaged successfully,and its expression is efficient and stable.
出处 《中国妇幼保健》 CAS 2015年第3期427-431,共5页 Maternal and Child Health Care of China
基金 广西科技基础条件平台建设项目〔11-031-07 12-071-05 13-051-12〕 广西医疗卫生重点科研课题〔2012061〕 广西医学科学实验中心开放基金专项项目〔KFJJ2010-15〕
关键词 Β-地中海贫血 人β-珠蛋白基因 慢病毒 β-thalassemia Human β-globin gene Lentivirus
  • 相关文献

参考文献7

  • 1杨颖,戴碧涛.β-地中海贫血的铁超载及去铁治疗[J].儿科药学杂志,2011,17(3):58-61. 被引量:15
  • 2Calmels B, Ferguson C, Laukkanen MO, et al. Recurrent retrovi- ral vector integration at the Mdsl/Evil locus in nonhuman pri- mate hematopoietic cells [ J ]. Blood,2005,106 (7) :2530 - 2533. 被引量:1
  • 3Dave UP, Akagi K, Tripathi R, et al. Murine leukemias with retroviral insertions at Lmo2 are predictive of the leukemias in- duced in SCID - X1 patients following retroviral gene therapy [J] . PLoS Genet, 2009, 5 (5) : e1000491. 被引量:1
  • 4Shieh J J, Liu KT, Huang SW, et al. Modification of alterna- tive splicing of Mcl - 1 pre - mRNA using antisense morpholino oligonucleotides induces apoptosis in basal cell carcinoma cells[J] . J Invest Dermatol, 2009, 129 (10) : 2497 -2506. 被引量:1
  • 5Salvatori F, Breveglieri G, Zuceato C, et al. Production of beta - globin and adult hemoglobin following G418 treatment of erythroid precursor cells from homozygous beta (0) 39 thalassemia patients [J] . Am J Hematol, 2009, 84 ( 11 ) : 720 - 728. 被引量:1
  • 6Sazani P, Kole R. Therapeutic potential of antisense oligonu- eleotides as modulators of alternative splicing [J] . J Clin In- vest, 2003, 112 (4): 481-486. 被引量:1
  • 7Schambach A, Baum C. Clinical application of lentiviral vec- tors - concepts and practice[J] . Curr Gene Ther, 2008, 8 (6) : 474 - 482. 被引量:1

二级参考文献29

  • 1胡亚美.诸福堂实用儿科学[M].第五版.北京:人民卫生出版社,2002:1766. 被引量:1
  • 2Britton RS,Leicester KL,Bacon BR.Iron toxicity and chelation therapy[J].Int J Hematol,2002,76(3):220-221. 被引量:1
  • 3Alan R Cohen,Renzo Galanello,Dudley J Pennell,et al.Thalas-semia[J].Hematology Am Soc Hematol Educ Program,2004VN:14-34. 被引量:1
  • 4Atiq M,Balia M,Ahmed US.Cardiac disease in beta-thalas-saemia major:is it reversiblel[J].Singapore Med J,2006,47(8):693-695. 被引量:1
  • 5MA Tanner,R Galanello,C Dessi,et al.The Effect of Combined Therapy with Deferoxamine and Deferiprone on Myocardial Iron in Thalassemia[J].Circulation,2007,115:1876-1884. 被引量:1
  • 6De Sanctis V.Growth and puberty and its management in thalassaemia[J].Horm Res,2002,58 (Suppl 1):72-79. 被引量:1
  • 7Heshmat Moayeri,Zohreh Oloomi.Prevalence of Growth and Puberty Failure with Respect to Growth Hormone and Gonado-tropins Secretion in Beta-Thalassemia Major[J].Arch Iran Med,2006,9(4):331-333. 被引量:1
  • 8C Roth á A,Pekrun á M,Bartz á H,et al.Short stature and failure of pubertal development in thalassaemia major:evidence for hypothalamic neurosecretory dysfunction of growth hormone secretion and defective pituitary gonadotropin secretion[J].Eur J Pediatr,1997,156:778-781. 被引量:1
  • 9Al-Rimawi HS,Jallad MF,Amarin ZO,et al.Hypothalamic-pituitary-gonadal function in adolescent females with beta-thalassemia major[J].Int J Gynaecol Obstet,2005,90(1):44-46. 被引量:1
  • 10De Sanctis V,Eleftheriou A,Malaventura C,et al.Prevalence of endocrine complications and short stature in patients with thalassaemia major:a multicenter study by the Thalassaemia International Federation (TIF)[J].Pediatr Endocrinol Rev,2004,2(Suppl 2):249-255. 被引量:1

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部